1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.18%
Negative revenue growth while WEED.TO stands at 22.51%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.34%
Negative gross profit growth while WEED.TO is at 301.54%. Joel Greenblatt would examine cost competitiveness or demand decline.
-340.87%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-340.87%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-148.50%
Negative net income growth while WEED.TO stands at 70.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-145.28%
Negative EPS growth while WEED.TO is at 70.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-145.28%
Negative diluted EPS growth while WEED.TO is at 71.23%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.27%
Slight or no buybacks while WEED.TO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.36%
Reduced diluted shares while WEED.TO is at 2.13%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-32.18%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
3.33%
Positive FCF growth while WEED.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
1118.33%
5Y revenue/share CAGR 1.25-1.5x WEED.TO's 882.92%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
654.32%
3Y revenue/share CAGR above 1.5x WEED.TO's 261.42%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-339.33%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-2397.94%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-604.60%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-315.13%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-278.03%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-165.58%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
3215.35%
10Y equity/share CAGR 1.25-1.5x WEED.TO's 2289.38%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
2681.11%
5Y equity/share CAGR above 1.5x WEED.TO's 685.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
137.62%
3Y equity/share CAGR at 50-75% of WEED.TO's 232.74%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.81%
AR growth well above WEED.TO's 9.77%. Michael Burry fears inflated revenue or higher default risk in the near future.
35.48%
Inventory growth well above WEED.TO's 2.22%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.87%
Positive asset growth while WEED.TO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.31%
Positive BV/share change while WEED.TO is negative. John Neff sees a clear edge over a competitor losing equity.
7.25%
We have some new debt while WEED.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
10.80%
R&D growth drastically higher vs. WEED.TO's 3.71%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
20.12%
SG&A growth well above WEED.TO's 26.98%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.